Antibody chips for personalized oncology — the multiplexed protein profiling platforms enabling tumor-associated autoantibody detection, immune checkpoint biomarker quantification, and therapeutic response prediction representing the most clinically impactful application in cancer precision medicine — creates the most therapeutically consequential market segment, with the Antibody...